Quarterly report [Sections 13 or 15(d)]

NON CONTROLLING INTEREST (Tables)

NON CONTROLLING INTEREST (Tables)

3 Months Ended

Mar. 31, 2025

ROYALTY OBLIGATIONS NET

Schedule of net loss attributable to non-controlling interest

		BioCorRx Pharmaceuticals, Inc.				Joseph DeSanto MD
Net loss		$	(42,784	)		$	(10	)
Average Non-controlling interest percentage of profit/losses			24.2	%			35.0	%
Net loss attributable to the non-controlling interest		$	(10,354	)		$	(3	)

		BioCorRx Pharmaceuticals, Inc.				Joseph DeSanto MD
Net loss		$	(1,549	)		$	(892	)
Average Non-controlling interest percentage of profit/losses			24.2	%			35.0	%
Net loss attributable to the non-controlling interest		$	(375	)		$	(312	)

Schedule of changes in non-controlling interest

Balance, December 31, 2024		$	(234,812	)
Net loss attributable to the non-controlling interest			(10,357	)
Balance, March 31, 2025			(245,169	)

Balance, December 31, 2023		$	(128,834	)
Net loss attributable to the non-controlling interest			(687	)
Balance, March 31, 2024			(129,521	)